Highlights:
- Landmark EVRA trial provides first Level 1 evidence for early venous ablation
- Ultrasound-guided foam sclerotherapy of small saphenous vein as effective as endovenous laser ablation for venous clinical severity score and quality of life at one year
- Rick de Graaf: Five years of venous stenting—what comes next?
- Profile: Alun H Davies
